AA Signature provides an innovative approach to treatment planning that focuses on patient outcomes
Nadda chairs Joint Strategy Meeting with Line Ministries for TB Mukt Bharat Abhiyan- 100-Day Intensified Campaign
ICMR will continue to track trends in HMPV circulation throughout the year
Launch of new product range aligns with strategy to diversify into emerging applications with high growth potential
Real-world and long-term extension data, including updated results from post-launch evaluation of REMS Program, bolster growing body of evidence supporting the efficacy and safety profile of CAMZYOS
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
The patient has been isolated in a designated hospital and is currently stable
Report highlights significant improvements in adolescent well-being in India
Multidisciplinary central team deployed to assist Gujarat with epidemiological, environmental, and laboratory investigations of AES cases
The company will address these observations within the stipulated timeline
Subscribe To Our Newsletter & Stay Updated
